medigraphic.com
ISSN 1560-4381 (Print)

2020, Number 1

<< Back Next >>

Correo Científico Médico 2020; 24 (1)

Atopic dermatitis: physiopathology and its clinical implications

Leyva MMÁ, Rodríguez MY, Rodríguez DR, Mejía ASM, Luyo JLL

Language: Spanish
References: 35
Page:
PDF size: 409.45 Kb.


ABSTRACT

Atopic dermatitis, a chronic multifactorial inflammatory disease of the skin, presents a multifactorial and not well known complex physiopathology where genetic and environmental factors interrelate to favor the development of the disease. In this bibliographic review carried out in important databases such as the U.S. National Library of Medicine, SciELO, ClinicalKey and Cuban medical journals, the descriptor atopic dermatitis was used in English and Spanish. The main factors involved in the physiopathology of atopic dermatitis such as genetic factors, disorders of the immune system, epidermal dysfunction, the role of lipids, microbiota and environmental factors are described, aside from the practical application of this knowledge in the design of drugs to fight the disease.


REFERENCES

  1. Ricardo Alonso OE, Rodríguez Sánchez MB, Hernández Fernández M, Alonso González M. Aspectos de interés sobre la etiopatogenia de la dermatitis atópica. Rev Med Electrón. 2018 [citado 01/12/2019]; 40(4): 1139-1148. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242018000400019&lng=es

  2. Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, et al. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017[citado 01/11/2019]; 66(2):230-247. Disponible en: https://doi.org/10.1016/j.alit.2016.12.003

  3. Silvestre Salvador JF, Romero Pérez D, Encabo Durán B. Atopic Dermatitis in Adults: A Diagnostic Challenge. J Investig Allergol Clin Immunol. 2017[citado 01/12/2019]; 27(2):78-88. Disponible en: http://www.jiaci.org/revistas/vol27issue2_1.pdf

  4. Barbarot S, Aubert H, Bernier C, Stalder JF. Dermatitis atópica. EMC – Dermatología. 2016[citado 01/12/2019]; 50 (4): 1-22. Disponible en: https://doi.org/10.1016/S1761-2896(16)80892-4

  5. Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017[citado 01/12/2019]; 35(3):283–289. Disponible en: https://doi.org/10.1016/j.det.2017.02.002

  6. Mei-Yen Yong A, Tay YK. Atopic Dermatitis: Racial and Ethnic Differences. Dermatol Clin. 2017[citado 01/12/2019]; 35(3):395-402. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0733863517300360.pdf?locale=es_ES&searchIndex=

  7. Ramírez Soto M, Bedolla Barajas M, González Mendoza T. Prevalencia de asma, rinitis alérgica y dermatitis atópica en niños escolares en el Bajío de México. Rev Alerg Mex. 2018[citado 01/12/ 2019]; 65(4):372-378. Disponible en: http://dx.doi.org/10.29262/ram.v65i4.527

  8. Herrera Sánchez DA, Hernández Ojeda M, Vivas Rosales IJ. Estudio epidemiológico sobre dermatitis atópica en México. Rev Alerg México. 2019 [citado01/12/2019];66(2):192-204. Disponible en: http://dx.doi.org/10.29262/ram.v66i2.59

  9. Moreno Fernández P. Dermatitis atópica. En: González Borrego A, Gema Herrerías E. Protocolos de actuación en la farmacia ante los principales problemas dermatológicos. España: Sociedad Española de Farmacia Familiar y Comunitaria (SEFAC); 2016. p. 85-94.

  10. Dinulos JG, Trickett A, Crudele C. New science and treatment paradigms for atopic dermatitis. Curr Opin Pediatr. 2018[citado 01/12/2019]; 30 (1):161-168. Disponible en: https://journals.lww.com/co-pediatrics/fulltext/2018/02000/New_science_and_treatment_paradigms_for_atopic.24.aspx

  11. Ricardo Alonso OE, Rodríguez Sánchez MB, Hernández Fernández M, Alonso González M. Aspectos de interés sobre dermatitis atópica, su diagnóstico y tratamiento. Rev Med Electrón. 2019 [citado 01/12/2019] ; 41(2): 496-507. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242019000200496&lng=es

  12. Cid del Prado Izquierdo ML, Zarco Cid del Prado O, Visoso Salgado Á. Dermatitis atópica severa e hiper-IgE. Rev Alerg México. 2017 [citado02/12/2019]; 64( 4 ): 487-492. Disponible en: http://dx.doi.org/10.29262/ram.v64i4.281

  13. David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Adv Exp Med Biol.2017 [citado 02/12/2019];1027:21-37.Disponible en: https://link.springer.com/content/pdf/10.1007%2F978-3-319-64804-0_3.pdf

  14. Feldman SR, Cox LS, Strowd LC, Gerber RA, Faulkner S, Sierka D, et al. The Challenge of Managing Atopic Dermatitis in the United States. Am Health Drug Benefits. 2019[citado 01/12/ 2019]; 12(2): 83–93. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485648/pdf/ahdb-12-083.pdf

  15. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019[citado 01/12/ 2019]; 40(2): 84–92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399565/pdf/zsn84.pdf

  16. Cabanillas B, Brehler AC, Novak N. Atopic dermatitis phenotypes and the need for personalized medicine. Curr Opin Allergy ClinImmunol. 2017[citado 01/12/ 2019];17(4):309-315. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515628

  17. Al Afif KAM, Buraik MA, Buddenkotte J, Mounir M, Gerber R, Ahmed HM, et al. Understanding the Burden of Atopic Dermatitis in Africa and the Middle East. Dermatol Ther (Heidelb). 2019[citado 01/12/ 2019]; 9(2): 223–241. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522619/pdf/13555_2019_Article_285.pdf

  18. Saint Pierre G, Schulz M, Jauregui MF, Conei D. Asociación del déficit de vitamina D con patologías de la piel humana. Rev Argentina Dermatol. 2017 [citado 04/12/2019] ; 98( 2 ). Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2017000200001&lng=es

  19. Chiesa Fuxench ZC. Atopic Dermatitis: Disease Background and Risk Factors. Adv Exp Med Biol. 2017[citado 01/12/ 2019]; 1027:11-19. Disponible en: https://link.springer.com/chapter/10.1007%2F978-3-319-64804-0_2

  20. Chovatiya R, Silverberg JI. Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children. Children (Basel). 2019[citado 01/12/ 2019]; 6(10): 108. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826460/pdf/children-06-00108.pdf

  21. Sidbury R, Kodama S. Atopic dermatitis guidelines: Diagnosis, systemic therapy, and adjunctive care. Clin Dermatol. 2018[citado 01/12/2019]; 36(5):648-652. Disponible en: https://www.sciencedirect.com/science/article/pii/S0738081X18301378

  22. Di Domenico EG, Cavallo I, Capitanio B, Ascenzioni F, Pimpinelli F, Morrone A, et al. Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis. Microorganisms. 2019[citado 01/12/ 2019]; 7(9): 301. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780378/pdf/microorganisms-07-00301.pdf

  23. Strathie Page S, Weston S, Loh R. Atopic dermatitis in children. AFP. 2016[citado 01/12/ 2019]; 45 (5):293-296. Disponible en: https://www.racgp.org.au/download/Documents/AFP/2016/May/AFP-May-Clinical-Page.pdf

  24. Kido Nakahara M, Furue M, Ulzii D, Nakahara T. Itch in Atopic Dermatitis. Immunol Allergy Clin North Am. 2017[citado 01/12/ 2019];37(1):113-122.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0889856116300704

  25. Ashbaugh AG, Kwatra SG. Atopic Dermatitis Disease Complications. Adv Exp Med Biol. 2017[citado 01/12/2019]; 1027:47-55. Disponible en: https://link.springer.com/content/pdf/10.1007%2F978-3-319-64804-0_5.pdf

  26. Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, AngeliniG. The Role of the Environmental Risk Factors in the Pathogenesis and Clinical Outcome of Atopic Dermatitis. Biomed Res Int. 2019[citado 01/12/ 2019]; 2019: 2450605. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500695/pdf/BMRI2019-2450605.pdf

  27. Ortiz Salvador JM, Pérez Ferriols A. Phototherapy in Atopic Dermatitis Adv Exp Med Biol. 2017[citado 01/12/2019]; 996:279-286. Disponible en: https://link.springer.com/chapter/10.1007%2F978-3-319-56017-5_23

  28. Maldonado Gómez W, Chuan Ibáñez J, Guevara Vásquez G, Gutiérrez C, Sosa Flores J. Asociación entre lactancia materna exclusiva y dermatitis atópica en un hospital de tercer nivel de atención. Rev Peruana Med Exp Salud Pública. 2019[citado 10/12/2019]; 36(2):239-46. Disponible en: http://dx.doi.org/10.17843/rpmesp.2019.362.4180

  29. Mitchell EA, Beasley R, Bjorkstén B, Crane J, García-Marcos L, Keil U. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy. 2013[citado 01/12/ 2019];43 (1): 73–84. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.12024

  30. Czarnowicki T, Krueger JG, Guttman Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol. 2017[citado 01/12/2019];139(6):1723-1734. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0091674917306656?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0091674917306656%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F

  31. Draelos ZD, Feldman SR, Berman B, Olivadoti M, Sierka D, Tallman AM, et al. Tolerability of Topical Treatments for Atopic Dermatitis. Dermatol Ther (Heidelb).2019[citado 01/12/2019]; 9(1): 71–102. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380975/pdf/13555_2019_Article_280.pdf

  32. Morgado Carrasco D, Fustà Novell X, Riera Monroig J, Iranzo P. FR-Después de décadas sin novedades, nuevos fármacos prometen revolucionar el tratamiento de la dermatitis atópica. Actas Dermosifiliogr. 2017[citado 01/12/2019]. Disponible en: http://dx.doi.org/10.1016/j.ad.2017.08.011

  33. Campana R, Dzoro S, Mittermann I, Fedenko E, Elisyutina O, Khaitov M, et al. Molecular aspects of allergens in atopic dermatitis. Curr Opin Allergy ClinImmunol. 2017[citado 01/12/ 2019]; 17(4):269-277.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392175

  34. Cotter DG, Schairer D, Eichenfield L. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018[citado 02/12/2019];78(3 Suppl 1):53-62. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0190962217328207?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0190962217328207%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F

  35. Aoki V, Lorenzini D, Orfali RL, Zaniboni MC, Prado de Oliveira ZN, Rivitti Machado MC, et al. Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology. An Bras Dermatol. 2019[citado 01/08/2019]; 94(2 Suppl 1): 67–75. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544038/pdf/abd-94-02-s1-0067.pdf




2020     |     www.medigraphic.com